Identification of a suitable cell source and bioactive agents guiding cell differentiation towards tenogenic phenotype represents a prerequisite for advancement of cellbased therapies for tendon repair. Human adipose-derived stem cells (hASCs) are a promising, yet intrinsically heterogenous population with diversified differentiation capacities. In this work, we investigated antigenically-defined subsets of hASCs expressing markers related to tendon phenotype or associated with pluripotency that might be more prone to tenogenic differentiation, when compared to unsorted hASCs. Subpopulations positive for tenomodulin (TNMD+ hASCs) and stage specific early antigen 4 (SSEA-4+ hASCs), as well as unsorted ASCs were cultured up to 21 days in basic medium or media supplemented with TGF-β3 (10 ng/ml), or GDF-5 (50 ng/ml). Cell response was evaluated by analysis of expression of tendon-related markers at gene level and protein level by real time RT-PCR, western blot, and immunocytochemistry. A significant upregulation of scleraxis was observed for both subpopulations and unsorted hASCs in the presence of TGF-β3. More prominent alterations in gene expression profile in response to TGF-β3 were observed for TNMD+ hASCs. Subpopulations evidenced an increased collagen III and TNC deposition in basal medium conditions in comparison with unsorted hASCs. In the particular case of TNMD+ hASCs, GDF-5 seems to influence more the deposition of TNC.
| INTRODUCTION
Tendons are specialized connective tissues that transmit forces between muscles and bones, and thus enable body motion. Tendon injuries are prevalent injuries among musculoskeletal conditions, affecting competitive and recreational athletes to the sedentary population, hence imposing a serious social and economic burden on the society.
Due to low cellularity, poor vascularization, and innervation tendons possess limited intrinsic healing capacity (Sharma & Maffulli, 2006) . Clinical management of tendon injuries remains highly challenging, offering less than satisfactory long-term treatment outcomes. Though there has been an increasing interest in application of tissue engineering approaches, identification of a suitable cell source and bioactive agents guiding cell differentiation towards tenogenic phenotype, represents an obvious prerequisite for advancement of such strategies.
Several cell populations have been investigated for tendon therapy, ranging from embryonic to terminally differentiated cells (Schneider, Angele, Järvinen, & Docheva, 2017) , each with its own limitations, such as cell scarcity and donor site morbidity in the case of tenocyte isolation, or ethical and safety concerns related to the use of embryonic stem cells (ESCs; J. Thomson et al., 1998) . In this context, mesenchymal stromal/stem cell (MSC) populations isolated from adult tissues may represent a more clinically relevant and preferential cell source. Particularly, adipose-derived stromal/stem cells (ASCs) offer abundance and ease of isolation by a minimally invasive procedure (Jurgens et al., 2008) , while sharing several key characteristics with bone marrow-derived counterparts (Wagner et al., 2005; Zuk et al., 2001) . Nevertheless, 'standard' isolation methodologies based on enzymatic digestion of adipose tissue and plastic adherence yield a highly heterogeneous population, representing a mixture of stem and progenitor cells in different stages of lineage commitment, with varying differentiation capacities (Mitchell et al., 2006; Yoshimura et al., 2006; Zuk et al., 2002) . Clonal analysis of human ASCs revealed that only 21% of clones were tripotent, whereas 31% and 29% were classified as bi-and unipotent, respectively (Guilak et al., 2006) . Importantly, it is postulated that specific modifications in isolation procedures and culture conditions may favour selection and expansion of specific cell subsets, despite phenotypically identical starting populations. As it is increasingly recognized that the intrinsic heterogeneity of MSC preparations has its functional consequences and determines the efficacy of therapeutic applications, several studies aiming at identification of stem cell subpopulations prone to a specific lineage differentiation are being investigated (Pérez-Silos, Camacho-Morales, & Fuentes-Mera, 2016) .
These approaches are usually based on selection of antigenically defined subsets, employing fluorescence activated cell sorting (FACS), or magnetic activated cell sorting (MACS). However, MSC phenotype is subjected to dynamic changes along culture time in vitro and some surface molecules recommended for MSC description (Zuk et al., 2002) , such as CD105, CD90 and CD73 are also found on other cell populations, like endothelial cells, smooth muscle cells, or fibroblasts (Mitchell et al., 2006; Zuk et al., 2001) . Consequently, there is an ongoing search for alternative 'stemness' markers enabling enrichment in cells that exhibit high CFU-Fs and multipotency, or even ESC-like features (Lv, Tuan, Cheung, & Leung, 2014) .
Stage specific embryonic antigen 4 (SSEA-4) is one of surface markers commonly employed to describe pluripotent cells, such as ESCs and induced pluripotent stem cells (iPSCs; Adewumi et al., 2007; Thomson, 1998) . SSEA-4 is a globoseries glycolipid that was first used to delineate changes during mouse embryonic development (Shevinsky, Knowles, Damjanov, & Solter, 1982) . Prospects on a subset of cells within the human adipose tissue that expresses a SSEA-4 marker, could assume a stem cell population more likely to commit to desirable phenotypes. Tenomodulin (TNMD) represents a type II transmembrane glycoprotein that is mainly expressed in hypovascular connective tissues, such as tendons, ligaments and skeletal muscle epimysium (Brandau, Meindl, Fässler, & Aszódi, 2001; Shukunami, Oshima, & Hiraki, 2001; Yamana et al., 2001) . It is also found in sclera and cornea of the eye, chordae tendineae in the heart and adipose tissue (Kimura et al., 2008; Oshima, Shukunami, Honda, Nishida, & Tashiro, 2003; Saiki et al., 2009) . Although its function in vivo is not fully understood yet, genetic studies using TNMD knockout model revealed that TNMD deficient mice displayed reduced cell density and proliferation, as well as abnormally increased collagen fibril diameters in postnatal tendons (Docheva, Hunziker, Fassler, & Brandau, 2005) . Loss of TNMD expression in Tendon Stem/Progenitor Cells (TSPCs) resulted in decreased proliferation and clonogenicity, together with earlier onset of senescence in knockout TSPCs, when compared to wild type cells (Alberton et al., 2015) . Interestingly, recent reports from our group and others suggest that enrichment in TNMD expressing cells (Goncalves, Gershovich, Rodrigues, Reis, & Gomes, 2018; Hou et al., 2017) , or induction of TNMD expression (Jiang et al., 2017) results in MSC populations with superior tenogenic differentiation potential.
Growth factors (GFs) represent signalling molecules potent at regulation of cell proliferation and differentiation and are commonly employed in TE strategies. Specifically, the transforming growth factor beta (TGF-β) superfamily plays a crucial role in tendon development and healing. Disruption of TGF-β signalling in TGF-β2 −/− and TGF-β3 −/− double mutant embryos resulted in the loss of tendons and ligaments in limbs, trunk, tail and head (Pryce et al., 2009 ). Furthermore, TGF-β3 is the main inducer of scleraxis, an early expressed tendon marker (Perucca Orfei et al., 2019) , acting as a potential trigger of tenogenesis. TGF-β3 has also been described to decrease tendon adhesion and promote tendon healing (Jiang et al., 2016) , highlighting TFG-β3 as a molecule of interest in tendon biology and regenerative mechanisms. Additionally, growth differentiation factors (GDFs) that constitute a subfamily of bone morphogenetic proteins (BMPs) contribute to tendon maintenance and repair. GDF 5, 6 and 7 promoted ectopic neotendon/ligament formation in rats (Wolfman et al., 1997) .
GDF-5 deficient mice demonstrated disrupted tail and Achilles tendon phenotype and delayed tendon healing after injury (Chhabra et al., 2003) . TGF-β3 and GDF-5 have been shown to improve tendon healing in tendon injury models and promote tenogenic differentiation of MSCs (James, Kumbar, Laurencin, Balian, & Chhabra, 2011; Leung, Jana, Tsao, & Zhang, 2013; Manning et al., 2011) .
Nevertheless, to date no single factor has been identified as required and sufficient for tendon progenitor specification. It is expected that a particular balance between transcriptional regulators relevant for several mesenchymal lineages determines their tenogenic commitment. Improved understanding of the effects of single growth factors may thus facilitate a rational design of more complex arrays investigating combinatorial effects of several molecules applied simultaneously or sequentially.
In the present study it was hypothesised that antigenically-defined subpopulations of ASCs that express markers related to tendon phenotype, or usually associated with pluripotency might be more prone to differentiate towards tenogenic lineage, when compared to full, unsorted ASC fraction. It was further hypothesised that such subsets might respond more effectively to biochemical cues provided by culture media supplemented with GFs for the induction of tenogenic commitment, namely TGF-β3 and GDF-5, as referred above. To test this hypothesis, unsorted ASCs and subpopulations positive for either TNMD or SSEA-4 were cultured up to 21 days in standard conditions (CTR) or media supplemented with TGF-β3 (10 ng/ml), or GDF-5 (50 ng/ml). GF concentrations were selected on the basis of published reports. Cell response to biochemical stimulation was evaluated weekly by analysis of gene expression profile of tendon-related markers and deposition of extracellular matrix (ECM) proteins.
| MATERIALS AND METHODS

| Cell isolation and subpopulation sorting
Human liposuction aspirates were obtained from healthy females (n = 3) with an average age of 42 years, under informed consent, according to the protocols previously approved by the Ethical Committee of Hospital da Prelada (Porto, Portugal). hASCs were isolated from lipoaspirates employing enzymatic digestion, as described previously (Zhu, Heydarkhan-Hagvall, Hedrick, Benhaim, & Zuk, 2013) . Briefly, tissues were rinsed in phosphate buffered saline (PBS) and immersed in 0.05% (w/v) collagenase type II (Sigma/C6885) solution for 1 hr at 37°C, under continuous agitation. The suspension was then centrifuged for 10 min at 800 ×g at 4°C and supernatant was discarded.
Remaining pellet, identified as stromal vascular fraction (SVF), was suspended and plated in Minimum Essential Medium (α-MEM, Alfagene) supplemented with 10% (v/v) Fetal Bovine Serum (FBS, Alfagene) and 1% (v/v) antibiotic/antimycotic solution (A/A, Alfagene).
Cells were incubated in a humidified atmosphere at 37°C with 5% CO 2 for 24 hr, and then washed extensively with PBS to remove residual erythrocytes. Culture medium was replaced every 3 days and cells were subcultured at 80% confluence.
hASCs subpopulations expressing either SSEA-4 or tenomodulin were sorted using magnetic beads (Dynabeads® M-450 Epoxy, Invitrogen) precoated with anti SSEA-4 (Santa Cruz Biotechnology, sc-59368), or anti tenomodulin (Santa Cruz Biotechnology, antibodies, according to the manufacturer's instructions, as described in detail elsewhere (Gonçalves, Gershovich, Rodrigues, Reis, & Gomes, 2018). Tenomodulin is a single-pass type II membrane protein, and the deduced 317 amino acid protein contains an N-terminal transmembrane domain. This antibody was raised against a peptide mapping within a C-terminal extracellular domain of Tenomodulin of human origin.
hASCs were subjected to the sorting procedure at passage P1 and selected cell populations were expanded in basal medium, namely α-MEM supplemented with 10% FBS and 1% A/A. Three days after immunomagnetic sorting, TNMD+ hASCs and SSEA-4+ hASCs were fixed in 10% neutral buffered formalin (Thermo Fisher Scientific) for 20 min at room temperature (RT), washed with PBS and permeabilized with 0,1% (v/v in PBS) Triton X-100 (Sigma Aldrich) for 20 min at RT.
After blocking with 1% (w/v in PBS) bovine serum albumin (Sigma Aldrich) for 1 hr at RT, primary antibodies against Tenomodulin or SSEA-4 were incubated overnight at 4°C. Cells were then washed with PBS, incubated with corresponding Alexa Fluor 488-conjugated secondary antibodies for 1 hr at RT and counterstained with 4′,6diamidino-2-phenylindole (DAPI, Sigma Aldrich, D9542, 1 μg/ml in PBS). All samples were visualized using a fluorescent microscope (Axio Imager Z1m, Zeiss) equipped with a digital camera (AxioCam MRm3).
| Induction of tenogenic differentiation by biochemical stimulation
To evaluate susceptibility of studied hASCs populations to tenogenic differentiation, unsorted hASCs fraction, SSEA-4 positive subpopulation (SSEA-4+ hASCs) and tenomodulin positive subpopulation (TNMD+ hASCs) were subjected to long-term culture in media supplemented with GFs. On the basis of previously published reports and own preliminary data, TGF-β3 and GDF-5 in concentrations of 10 ng/ml and 50 ng/ml respectively, were chosen for the present study. For every cell population under investigation, cells in passage P3 were seeded in 24-well plates at a density of 10 3 cells/cm 2 . Differentiation media were composed of α-MEM supplemented with 10% FBS, 1% A/A (basal medium), 2 mM L-glutamine (STEMCELL™ Technologies), 0.2 mM ascorbic acid (Wako) and TGF-β3 (Peprotech, 100-36E) or GDF-5 (Abcam, ab55329). Ascorbic acid was included in the media to promote collagen synthesis (Barnes, 1975) . Basal culture medium without GFs was considered control condition (CTR). Media compositions are summarized in Table 1 . Cell response to biochemical stimulation was evaluated weekly up to 21 days by analysis of expression of tendon-associated markers on gene level and protein level, by real time PCR, immunocytochemistry and western blotting. Three independent experiments were carried out.
TABLE 1 Culture media composition used in the study
Medium Composition
CTR
Basic medium: αMEM + 10% FBS + 1% A/A TGF-β3 Basic medium + 2 mM L-glutamine + 0.2 mM ascorbic acid + TGF-β3 (10 ng/ml) GDF-5 Basic medium + 2 mM L-glutamine + 0.2 mM ascorbic acid + GDF-5 (50 ng/ml)
| Metabolic activity and proliferation
The cellular metabolic activity was evaluated by MTS assay (Cell Titer 96® Aqueous Solution Cell Proliferation Assay, Promega). Cells were rinsed in PBS before being 3 hr incubated in a mixture of FBS-free and phenol red free medium and MTS solution (5:1 ratio) at 37°C and 5% CO 2 atmosphere. Then, 100 ml of each sample was transferred to a new 96-well plate and the absorbance read at 490 nm (Synergy HT, Bio-TeK Instruments). Triplicates were made of each sample and a blank reading was performed. Cell proliferation was assessed by Quant-iT PicoGreen dsDNA Assay Kit (P7589, Invitrogen). Samples were collected into microtubes with 1 ml of ultrapure water and stored at −80°C. Then, samples were thawed, sonicated (VCX-130PB-220, Sonics) and analyzed using a microplate reader with an excitation of 485/20 nm and an emission of 528/20 nm. Samples and standards were made in triplicate.
| RNA extraction, reverse transcription and real time RT-PCR
To analyze gene expression, total RNA was isolated using TRI Reagent® (Sigma Aldrich) according to the manufacturer's instructions. RNA concentration and purity were determined spectrophotometrically using NanoDrop ND-1000 (Thermo Fisher Scientific).
500 ng of total RNA were reversely transcribed using qScript™ cDNA Synthesis Kit (Quanta Biosciences), following manufacturer's protocol.
Primers were designed using Primer-BLAST tool and are summarized in (annealing) and 20 s at 72°C. The fluorescence signal was measured after the extension step at 72°C and melting curves were generated at the end of the cycling to verify specificity of PCR products. 2 −Ct method (Livak & Schmittgen, 2001 ) was employed to evaluate relative gene expression and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as reference gene. All values were first normalized to GAPDH, and then to CTR medium condition in unsorted hASCs at 7 days. Samples were collected and analyzed in triplicates.
| Immunocytochemistry
To evaluate expression of tendon-related ECM components, immunocytochemical analysis was performed. Cells were seeded on coverslips in a 24-well plate at a density of 1 × 10 3 cells/cm 2 . After respective time in culture, cells were fixed with 10% neutral buffered formalin 
| Statistical analysis
| RESULTS
Human ASCs were isolated from lipoaspirates and subpopulations expressing either TNMD (TNMD+ hASCs) or SSEA-4 (SSEA-4+ hASCs)
were successfully sorted using immunomagnetic beads preconjugated with specific antibodies against the antigens of interest (Figure 1 ).
No significant differences in metabolic activity or proliferation rate were observed between unsorted hASCs and selected subpopulations, indicating that sorting procedure employed for TNMD+ and SSEA-4+ cells isolation did not affect cell viability (Figure 2 ). These observations were in accordance with our previous studies, where this sorting strategy was effectively utilized (Gonçalves et al., 2018; Rada, Gomes, & Reis, 2011) . The metabolic activity and proliferation increase with time in culture (p < .05) in all cell populations. Moreover, SSEA-4+ hASCs are more proliferative in TGF-β3 supplemented medium at 14 and 21 days than in medium supplemented in GDF-5 or in basal medium (p < .01).
To evaluate susceptibility of studied hASCs populations to tenogenic differentiation, unsorted hASCs fraction, SSEA-4+ hASCs and TNMD+ hASCs were subjected to long-term culture in the presence of TGF-β3 or GDF-5. Unsupplemented culture medium (CTR) served as control culture condition.
| Gene and protein expression analysis of tendon related markers
In order to determine the propensity of selected hASCs populations to commit towards tendon-like phenotype, gene expression levels of tendon associated markers were studied using real time RT-PCR.
It was demonstrated that treatment with TGF-β3 resulted in signif- Considering the critical role of ECM composition and organization for tendon phenotype and function, gene expression of major structural components (Figure 5a ) and proteins involved in regulation of collagen fibril assembly (Figure 5b) were further investigated.
The expression of COL1A1 is low for both unsorted hASCs and subpopulations and tends to decrease with the time in culture being close to baseline levels after 21 days regardless of cell media or cell populations ( Figure 5a ). An 8-fold increase is observed in COL3A1 levels of the unsorted population cultured in basal and GDF-5 supplemented medium at day 14 relative to control conditions. In the presence of TGF-β3 there is an 18-fold increment in comparison with control values.
At 14 days, the transcript levels of COL3A1 are also increased in SSEA-4+ hASCs over control conditions in basal medium and media supplemented with TGF-β3 and GDF-5 by 10-fold, 17-fold and 16-fold change, respectively. After 21 days in culture the COL3A1 levels of SSEA-4+ hASCs are lower than the ones found for unsorted hASCs.
Interestingly, TNMD+ hASCs evidence the lowest COL3A1 levels of all cell populations studied, barely reaching the 2-fold increase over baseline after 14 days in culture. The expression is lower in respect to the unsorted hASCs independently of the culture media and to SSEA-4+ hASCs population supplemented with both growth factors: TGF-β3
and GDF-5 (p > .05; Figure 5a ). 
| Evaluation of ECM deposition
The expression of tendon structural proteins was further evaluated on the protein level. To characterize the matrix synthesized by selected hASC populations under different culture conditions, the deposition of collagen type I (COL1), collagen type III (COL3) and tenascin C (TNC) was investigated by immunocytochemistry ( Figure 6 ).
Protein quantification was assessed at day 21 for all conditions studied. Collagen type I is highly detected in the different cell populations apart from the culture media conditions. Unlike COL1, the deposition of COL3 varies with cell population and culture media. In unsorted hASCs COL3 is almost residual, independently of the culture conditions with a slight increase (p > .05) with the supplementation of TGF-β3. In the case of SSEA-4+ hASCs, the COL3 levels are high only in basal culture medium (**p < .01). Both hASCs subpopulations evidence increased production of COL3 relative to unsorted hASCs (**p < .01). In particular, TNMD+ hASCs shows the highest values of COL3 independently of the culture medium (in comparison with unsorted hASCs and to SSEA-4+ hASCs cultured in growth factor supplemented media, p < .05).
Although TGF-β3 and GDF-5 seem not to play an incremental role in COL1 and COL3 production by hASCs populations, these growth factors improve the production of TNC in the unsorted hASCs (p < .05), with particular effect on TGF-β3 cultures. However, the deposition of TNC by SSEA-4+ hASCs is decreased in growth factor supplemented medium (in relation to basal medium conditions, p < .05). Interestingly, TNMD+ subpopulation shows dissimilar responses to TGF-β3 and GDF-5. In TGF-β3 cultures the TNC is lower than in basal medium while the stimulation of GDF-5 increases the production of this protein.
Overall, GFs seem to play a role in the synthesis and deposition of ECM molecules present in tendon tissues, stimulating the hASCs subsets in different ways.
| DISCUSSION
Adipose-derived stromal/stem cells represent a highly promising cell source for tissue engineering and regenerative medicine approaches that is currently being studied for a broad range of applications (Frese, Dijkman, & Hoerstrup, 2016; Gimble, Bunnell, & Guilak, 2012) , including tendon engineering and regeneration (De Mattos Carvalho et al., 2011; James et al., 2011; Uysal, Tobita, Hyakusoku, & Mizuno, 2012 (Johal, Lees, & Reid, 2015; Mo, Wang, Zhou, Li, & Wu, 2016) .
Remarkably, mobilized peripheral blood CD34+ progenitors have been already employed clinically for the prevention of graft-versus-hostdisease in HLA-mismatched recipients (Handgretinger et al., 2001) and for the treatment of refractory angina (Henry et al., 2016) . Furthermore, several preclinical studies reported utility of MSC subpopulations for various orthopaedic applications, for instance, CD105depleted ASCs demonstrated enhanced osteogenic differentiation, whereas CD271+ cells from synovial membrane improved cartilage repair (Pérez-Silos et al., 2016) .
Following this concept, we assessed the response of SSEA-4positive and TNMD-positive subpopulations in comparison with unsorted hASCs cultured up to 21 days either in basic medium or media supplemented with TGF-β3 or GDF-5.
The cell subpopulations were successfully sorted from the crude population. We selected extra/pericellular domains for antibody bonding avoiding permeabilization of the cell membrane or other invasive methodologies, which may cause membrane rupture and release of cell content to enable viable cells and not to perturb cell responses as much as possible. Moreover, intracellular molecules are typically more immature and consequently may differ from the molecules expressed at the surface or extracellularly in terms of protein functionality and recognition. Thus, we investigated surface proteins previously assessed by our group (Goncalves et al., 2018; Mihaila et al., 2013) .
As expected, cell metabolic activity increases along the time in culture in all conditions studied. Our data also show that cell proliferation increases from 7 to 14 days in culture and that SSEA-4+ hASC proliferation is stimulated by the TGF-β3 supplementation in comparison with GDF-5 and to control conditions after 14 days in culture. Despite that no studies have reported on the susceptibility of SSEA-4+ cells to TGF-β3, it is known that the TGF-β superfamily plays crucial roles in cell processes including cell proliferation (Hao, Varshney, & Wang, 2008) . Between 14 and 21 days in culture, no significant differences were observed in the proliferation and metabolic activity of the different cell populations, which may be related to cell confluency.
In order to evaluate the capability of selected hASCs populations to tenogenic commitment, we then investigated the expression of a panel of tendon-related markers on both gene level and protein level, bearing in mind that none of them is expressed exclusively in tendon tissue (Taylor et al., 2009) .
In our study, the gene expression was normalized to the keeper GAPDH. Although comparative reports have suggested other reference genes in osteogenic and cartilage differentiation studies, there is a lack of comparative reports on the most suitable reference genes for the reproducibility analysis of tenogenic markers by hASCs. Thus, following previous published studies performed by us (Gonçalves et al., 2013 , Mihaila et al., 2014 , Goncalves et al., 2018 and by others (Bi et al., 2007) , GAPDH was selected as genetic reference. To allow direct comparison between sorted and unsorted cells, gene expression levels were expressed relative to control conditions at day 7 in unsorted hASCs.
We first focused on the expression of scleraxis and tenomodulin that are considered, respectively, early and late markers of tenogenic lineage. Scleraxis is a basic helix-loop-helix transcription factor and to date the best studied early marker of tendon progenitor cells. During embryonic development, it is first detected in the developing limb buds and in syndetome, and its expression is maintained at later stages of tendon formation up to fully differentiated cells (Cserjesi et al., 1995) . Consistent with the previous findings identifying TGF-β signalling as a potent inducer of SCX expression, critical for tendon progenitor maintenance (Pryce et al., 2009 ), a significant up-regulation of SCX was demonstrated for all cell populations cultured for 14 days in the presence of TGF-β3 in our study (p < .05). SCX expression decreases from 14 to 21 days in culture in unsorted hASCs and SSEA-4+ hASCs (p < .05), which is expected since SCX is considered to be an early tendon marker. The incremental response of scleraxis expression to TGF-β has been suggested to be mediated by the canonical Smad signaling pathway (Czubryt, 2012) . Moreover, TGF-β3 as inducer of scleraxis (Perucca Orfei et al., 2019) , acts as a potential biomolecular trigger of tenogenesis and can inhibit later markers (Perucca Orfei et al., 2019) .
Interestingly, the expression of TNMD showed basal levels in all cell populations, including in the TNMD+ hASCs. Although Liu et al. showed that ectopic SCX expression alone was not sufficient to trigger TNMD expression in murine MSCs (Liu et al., 2014) , the TNMD expression in our study may be influenced by the up-regulation of SCX, a likely regulator of the TNMD gene. Qi J et al. (Qi et al., 2012) reported that knockdown of TNMD increased the expression of both scleraxis and myostatin in tenocytes, indicating a potential negative feedback loop between TNMD and its regulators.
Considering that tendons are composed mainly of extracellular matrix arranged in a complex hierarchical manner, we then focused on the expression patterns of critical structural components and molecules controlling their spatiotemporal assembly. In particular, collagen type I represents approximately 95% of the total collagen content and around 60% of tissue dry mass (Wang, 2006) . Collagen type III is in turn expressed early in tendon development, playing a role in initial fibril assembly and control of fibril diameters, while its expression in mature tendon is restricted to endotenon and epitenon (Wang, 2006) .
COL1A1 and COL3A1 transcript levels were slightly decreased after 14 days of culture of TNMD+ hASCs supplemented with TGF-β3.
However, in the case of unsorted cells and SSEA-4+ hASCs these levels remained stable between different conditions and with time.
In our study, COL1A1 transcripts tend to decrease to baseline levels in all cell populations with the time in culture. Although the FIGURE 1 Micrographs of SSEA-4+ hASCs (a) and TNMD+ hASCs (b) 3 days after sorting on Dynabeads® M-450 Epoxy, 10× magnification. SSEA-4 (c) and TNMD (d) immunostaining (green) in SSEA-4+ and TNMD+ hASCs, respectively, 3 days after sorting. Nuclei are stained with DAPI (blue) expression of COL3A1 also decreases, the COL3A1 levels are considerable higher than those of COL1A1 at 14 days. Collagen III expression decreases gradually during development and increases after injury likely contributing to the matrix remodeling during the healing process.
The high levels of COL3A1 by 14 days in comparison with control conditions suggests that collagen III could be participating in the in vitro fibrilogenesis of hASCs populations. As the fibrilogenesis occurs collagen III decreases, which is verified after 21 days in culture.
Decorin represents a prototype small leucine-rich proteoglycan (SLRP) displaying critical instructive roles in matrix assembly and signal transduction, due to its multivalent binding abilities (Chen & Birk, 2013) . It is a key modulator of collagen fibrilogenesis, capable of inhibiting lateral growth of collagen fibrils. In our study, unlike COL1A1
and COL3A1, DCN expression is not influenced by the time in culture, keeping expression levels high in unsorted hASCs and hASCs subpopulations. Decorin is high throughout development (Connizzo, Yannascoli, & Soslowsky, 2013) and its up-regulation in our study assists the synthesis of a tendon-like ECM. Decorin-based therapies have been investigated both as a target for antisense gene therapy to improve ligament healing by manipulation of early scar functional properties (Nakamura et al., 2000) and for suppressing fibrosis, motivated by its interference with TGF-β signalling (Schaefer & Schaefer, 2010) .
Tenascin C is a glycoprotein expressed in several tissues subjected to high tensile stress and it is involved in modulation of cell-matrix interactions. It is expressed during tendon embryonic development, whereas its expression in mature tissue is generally low (Burk et al., 2014; Taylor et al., 2009 ) and transiently elevated in response to tissue injury, when TNC mediates inflammatory and fibrotic processes (Chiquet-Ehrismann & Tucker, 2004) . Moreover, Tenascin C is significantly regulated by the tissue microenvironment and is required when active tissue modeling during embryogenesis or re-modeling after injury occurs (Brellier, Tucker, & Chiquet-Ehrismann, 2009 ).
The up-regulation of TNC in SSEA-4+ hASCs cultured in basal medium and GDF-5 supplemented medium and the lower expression of TNC in hASCs populations stimulated with TGF-β3 suggests that Cell-based approaches shall regard the extent of the expression of tendon ECM components identified as beneficial for tendon repair. In this context, cell population selected for this study respond to the cell culture conditions investigated. However, the cell subsets investigated seem to play a more prominent role than the growth factor supplementation especially at the protein level.
Overall, GFs seem to play a role in the synthesis and deposition of ECM molecules present in tendon tissues, stimulating the hASCs subsets in different ways. The production of collagens, especially COL3 by unsorted hASCs is influenced by TGF-β3, while SSEA-4+ hASCs do not require exogenous growth factors to produce COL3 FIGURE 3 Gene expression of scleraxis (SCX) and tenomodulin (TNMD) in unsorted hASCs, SSEA-4-positive and TNMD-positive subpopulations cultured up to 21 days in basic medium (CTR), or media supplemented with TGF-β3 or GDF-5. Gene expression levels were expressed relative to control conditions at day 7 in unsorted hASCs (control conditions). Data represent the mean ± SD; *p < .05, **p < .01, ***p < .001, ****p < .0001
FIGURE 4
Western blot analysis of scleraxis expression in unsorted hASCs, SSEA-4+ hASCs and TNMD+ hASCs cultured for 14 days in basic medium (CTR), or media supplemented with TGF-β3 or GDF-5. β-actin was used as loading control and TNC rich matrix. Higher amounts of COL3 are produced in TNMD+ hASCs independently of the growth factors supplemented to the culture medium but the presence of GDF-5 in the culture medium of TNMD+ cells improves the synthesis of TNC. The fact that TNC is also present at enthesis also suggests a potential application of hASCs subsets in the establishment of cell-matrix interactions for interfacial strategies.
Even though some limitations exist regarding the efficiency of immunomagnetic sorting, this technology raises the possibility of using cell subsets more prone to acquire lineage specific characteristics, maximizing their differentiation capacity as opposed to the entire hASCs population. This is of major relevance to further advancing the recreation of a microenvironment that potentiates tendon regeneration and this work is a step forward in that direction.
FIGURE 5 Gene expression of tendon ECM proteins: collagen type I (COL1A1), collagen type III (COL3A1), decorin (DCN) and tenascin C (TNC) in unsorted hASCs, SSEA-4-positive and TNMD-positive subpopulations cultured up to 21 days in basic medium (CTR) or media supplemented with TGF-β3 or GDF-5. Gene expression levels were expressed relative to control conditions at day 7 in unsorted hASCs. Data represent the mean ± SD; *p < .05, **p < .01, ***p < .001, ****p < .0001
| CONCLUSION
Identification of antigenically-defined subpopulations prone to differentiation towards specific cell lineages represents an attractive strategy to increase the effectiveness of cell-based therapies for musculoskeletal tissue engineering. In this study both SSEA-4+ hASCs and TNMD+ hASCs subsets produced increased amounts of tendon ECM proteins, namely collagen III and TNC in basal cultures in comparison with the crude hASCs. In particular, TNMD+ cells were found to be more susceptible to TGF-β3 conditioning at the gene level although GDF-5 also seems to play a role in the production of tendon ECM proteins by TNMD+ hASCs. The differential response of hASCs subsets to microenvironmental stimuli anticipates intrincated mechanisms where cell subpopulations likely have dedicated roles to be further unveiled. Thus, the complexity of biological responses might require a combinatorial approach to guide stem cells commitment towards tendon-like phenotype anticipating improved regenerative strategies for tendon tissues.
